Edgen Stock·Oct 08 2025, 09:38戻る
戻る
Takeda Expands Plasma-Derived Therapies Manufacturing in Japan with Significant Investment
Edgen Stock·Oct 08 2025, 09:38
[1] From atop Mt. Fuji, a Takeda team heralds a need for human plasma | PharmaVoice[2] Takeda Pharmaceutical's Strategic Expansion in Plasma-Derived Therapies: Manufacturing Capacity as a Catalyst for Long-Term Value Creation - AInvest[3] Amkor Technology Breaks Ground on New Semiconductor Advanced Packaging and Test Campus in Arizona; Expands Investment to $7 Billion | Morningstar